Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment for systemic sclerosis (SSc), but it also can cause immunological adverse events (iAEs). Therefore, we aimed to determine the frequency of iAEs [engraftment syndrome (ES) and secondary autoimmune disorder (s...
Main Authors: | Patrick-Pascal Strunz, Matthias Froehlich, Michael Gernert, Eva Christina Schwaneck, Anna Fleischer, Ann-Christin Pecher, Hans-Peter Tony, Joerg Christoph Henes, Marc Schmalzing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.723349/full |
Similar Items
-
Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications
by: Emanuele Cozzani, et al.
Published: (2021-06-01) -
A Double-blind, Randomized Controlled Trial of Ciplukan (Physalis angulata Linn) Extract on Skin Fibrosis, Inflammatory, Immunology, and Fibrosis Biomarkers in Scleroderma Patients
by: Sumartini Dewi, et al.
Published: (2019-10-01) -
Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease
by: Patrick-Pascal Strunz, et al.
Published: (2023-11-01) -
Training Course Results of the Assessment of Modified Rodnan Skin Score in Scleroderma
by: Gerçek CAN, et al.
Published: (2022-03-01) -
Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis
by: Chen Chen, et al.
Published: (2022-02-01)